Benign course of residual inflammation at end of treatment of liver transplant recipients after sofosbuvir based therapy

doi:10.4254/wjh.v14.i3.602

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 3

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4117)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-3) series.

Item

Count

PDF

175

WORD

HTML

1283

Figures (1-2)

217

Tables (1-3)

215

Sum=1972

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

203

Download

461

Sum=664

Publishing Process of This Article

Item

Count

Browse

366

Download

1115

Sum=1481

Mar 27, 2022 (publication date) through Jul 25, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

World J Hepatol. Mar 27, 2022; 14(3): 602-611
Published online Mar 27, 2022. doi: 10.4254/wjh.v14.i3.602

Full Size Figure Download Figure

Figure 1 Hepatitis C RNA during and after treatment.

Citation: Ismail B, Benrajab KM, Bejarano P, Ruiz P, Sears D, Tzakis A, Zervos XB. Benign course of residual inflammation at end of treatment of liver transplant recipients after sofosbuvir based therapy. World J Hepatol 2022; 14(3): 602-611
URL: https://www.wjgnet.com/1948-5182/full/v14/i3/602.htm
DOI: https://dx.doi.org/10.4254/wjh.v14.i3.602